Hi all, Just a brief update as I prepare for the next round of battle. My PSA is low and rising quickly (BCR, PSA 0.77 up from 0.47 a month ago and <0.5 8 months ago). About a 3-month doubling rate but nothing detected on scans so far.
Over the past weeks I've managed to get several opinions from terrific MOs, all recognized experts in advanced PCA. All recommend taking action soon.
One recommendation is either 6-9 months of ADT or a novel trial using a different pathway (HIF-2a) that has been effective in renal cancer and that would not disrupt testosterone.
Second recommendation is 6-9 months of ADT with intensification, probably abiraterone again, but possibly abieraterone + app;utamide. I previously had 18 months of abiraterone with EBRT after unsuccessful RALP and it yielded 18 months of PSA <0.5.
Third recommendation is 9 months of ADT + abiraterone + docetaxel. The addition of docetaxel is given the fast doubling rate and the fact that I am otherwise very healthy without symptoms.
All recommend another set of scans asap given PSA is likely approaching 1.0 and then spot treatment as available in addition to the above (earlier Axumin didn't detect anything at PSA 0.35), including Choline and PSMA PET Pylarify F-18.
I'm leaning toward door #3, adding docetaxel despite the side effects, thinking that in most similar settings (CRPC or mCSPC) earlier, intensive treatment has shown benefits.
Again, all three MOs are exceptionally experienced with PCA and seem very committed.
Time to get the additional scans and finalize the call this month.